☰

Kellye C. Kirkbride, Ph.D. - Publications

Affiliations: 
2007 Duke University, Durham, NC 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Li B, Orton D, Neitzel LR, Astudillo L, Shen C, Long J, Chen X, Kirkbride KC, Doundoulakis T, Guerra ML, Zaias J, Fei DL, Rodriguez-Blanco J, Thorne C, Wang Z, et al. Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors. Science Signaling. 10. PMID 28655862 DOI: 10.1126/Scisignal.Aak9916  0.326
2016 Sinha S, Hoshino D, Hong NH, Kirkbride KC, Grega-Larson NE, Seiki M, Tyska MJ, Weaver AM. Cortactin promotes exosome secretion by controlling branched actin dynamics. The Journal of Cell Biology. PMID 27402952 DOI: 10.1083/Jcb.201601025  0.374
2015 Li H, Miteva M, Kirkbride KC, Cheng MJ, Nelson CE, Simpson EM, Gupta MK, Duvall CL, Giorgio TD. Dual MMP7-proximity-activated and folate receptor-targeted nanoparticles for siRNA delivery. Biomacromolecules. 16: 192-201. PMID 25414930 DOI: 10.1021/Bm501394M  0.363
2014 Giorgio TD, Li H, Miteva M, Kirkbride KC, Cheng M, Nelson CE, Duvall CL. Abstract 720: Dual MMP-7-proximity-activated and folate-targeted nanoparticles for siRNA delivery Cancer Research. 74: 720-720. DOI: 10.1158/1538-7445.Am2014-720  0.402
2013 Hoshino D, Kirkbride KC, Costello K, Clark ES, Sinha S, Grega-Larson N, Tyska MJ, Weaver AM. Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Reports. 5: 1159-68. PMID 24290760 DOI: 10.1016/J.Celrep.2013.10.050  0.461
2012 Kirkbride KC, Hong NH, French CL, Clark ES, Jerome WG, Weaver AM. Regulation of late endosomal/lysosomal maturation and trafficking by cortactin affects Golgi morphology. Cytoskeleton (Hoboken, N.J.). 69: 625-43. PMID 22991200 DOI: 10.1002/Cm.21051  0.303
2011 Gatza CE, Holtzhausen A, Kirkbride KC, Morton A, Gatza ML, Datto MB, Blobe GC. Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth. Neoplasia (New York, N.Y.). 13: 758-70. PMID 21847367 DOI: 10.1593/Neo.11528  0.747
2011 Kirkbride KC, Sung BH, Sinha S, Weaver AM. Cortactin: a multifunctional regulator of cellular invasiveness. Cell Adhesion & Migration. 5: 187-98. PMID 21258212 DOI: 10.4161/Cam.5.2.14773  0.359
2010 Holtzhausen A, Gatza CE, Kirkbride KC. Abstract 3972: The role of the TGF-β type III receptor in colon carcinogenesis Cancer Research. 70: 3972-3972. DOI: 10.1158/1538-7445.Am10-3972  0.75
2009 Lee NY, Kirkbride KC, Sheu RD, Blobe GC. The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors. Molecular Biology of the Cell. 20: 4362-70. PMID 19726563 DOI: 10.1091/Mbc.E09-07-0539  0.677
2009 Gordon KJ, Kirkbride KC, How T, Blobe GC. Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2 Carcinogenesis. 30: 238-248. PMID 19056927 DOI: 10.1093/Carcin/Bgn274  0.712
2008 Kirkbride KC, Townsend TA, Bruinsma MW, Barnett JV, Blobe GC. Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor. The Journal of Biological Chemistry. 283: 7628-37. PMID 18184661 DOI: 10.1074/Jbc.M704883200  0.687
2007 Dong M, How T, Kirkbride KC, Gordon KJ, Lee JD, Hempel N, Kelly P, Moeller BJ, Marks JR, Blobe GC. The type III TGF-beta receptor suppresses breast cancer progression. The Journal of Clinical Investigation. 117: 206-17. PMID 17160136 DOI: 10.1172/Jci29293  0.706
2005 Kirkbride KC, Ray BN, Blobe GC. Cell-surface co-receptors: emerging roles in signaling and human disease. Trends in Biochemical Sciences. 30: 611-21. PMID 16185874 DOI: 10.1016/J.Tibs.2005.09.003  0.617
2003 Chen W, Kirkbride KC, How T, Nelson CD, Mo J, Frederick JP, Wang XF, Lefkowitz RJ, Blobe GC. Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Science (New York, N.Y.). 301: 1394-7. PMID 12958365 DOI: 10.1126/Science.1083195  0.66
2003 Kirkbride KC, Blobe GC. Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy. Expert Opinion On Biological Therapy. 3: 251-61. PMID 12662140 DOI: 10.1517/14712598.3.2.251  0.705
Show low-probability matches.